Clinical trial
Transcutaneous Electrical Acupoint Stimulation (TEAS) for the Treatment of Pain in Bone Metastases of Lung Cancer: A Multicenter Prospective RCT Study
NCT05730972 is registered in ClinicalTrials.gov with The Third Affiliated hospital of Zhejiang Chinese Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcutaneous Electrical Acupoint Stimulation (TEAS) for the Treatment of Pain in Bone Metastases of Lung Cancer: A Multicenter Prospective RCT Study
- Lead sponsor
- The Third Affiliated hospital of Zhejiang Chinese Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 15, 2023
- Completion date
- December 31, 2025
- Enrollment
- 188 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acupuncture, bone metastases, cancer pain, non small cell lung cancer